Xconomy: Esperion News, Articles and Opinions

“esperion” Archives

Entry	Author	Date	Location
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More	Frank Vinluan	04/24/20	National
Move West, Raise Cash: ProNAi’s Hot Streak Now Includes $138M IPO	Sarah Schmid Stevenson	07/16/15	Detroit Ann Arbor
FDA Cuts Limit on Esperion Cholesterol Drug, Considers Competitors	David Holley	07/07/15	Detroit Ann Arbor
MVCA Celebrates Year’s Top Deals, Names New Board Chair	Sarah Schmid Stevenson	11/08/13	Detroit Ann Arbor
Page 1 of 1

Underwriters and Partners

Xconomy Insight

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Sponsored · Whitepaper
The Importance of Early Key Opinion Leader Outreach in the Biologics & Biosimilars Marketplace
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
IBM Watson

Xconomy on Demand

We offer a number of ways to subscribe for free!